Command Palette

Search for a command to run...

Clinical Trials · NCT01499108

Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes

CompletedPhase 4Liraglutide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Peter Rossing
Enrollment
32
Start date
Aug 2012
Locations
1 site, Denmark
Primary endpoint
Change in ambulatory blood pressure
View Liraglutide compound reference